Skip to content
Sora Lifesciences
Healthcare (India)

Benchmarking women in leadership across Indian healthcare

A 150-organization benchmarking study of gender diversity practices across private hospitals and pharmaceutical companies in India, quantifying women's representation from entry level to the board.

Key offerings in this project
  • Ad-hoc Market Research Study
  • Benchmarking Study

The brief

  • Benchmark gender diversity practices and women's representation in leadership across private hospitals and pharma companies in India
  • Identify the drivers and barriers shaping women's advancement into senior roles, including policy, culture and structural enablers
  • Generate sector-specific recommendations to help organizations set targets and design interventions

The problem

No comparable benchmark on women's representation or the policies driving it across Indian hospitals and pharma

Our approach

A 10-minute online survey of 150 senior decision-makers, with weighted industry averages and significance testing at 95%

  • Surveyed 150 senior leaders: 110 hospitals and 40 pharma companies, April to May 2025
  • Screened to private hospitals with 200+ beds and pharma firms in manufacturing, R&D, devices and consumer health
  • Captured representation by level, policies, mentorship, attrition drivers and ecosystem needs
  • Applied industry weighted averages, 95% significance testing and cross-tabulations

Key outcomes

A sector benchmark linking leadership targets and policies to measurable gains in women's representation

  • Women hold 48% of the hospital workforce versus 28% in pharma, with representation falling from 44% at entry level to 24% in the C-suite
  • Identified the policy gaps holding women back, from leadership development to flexibility and relocation support
  • Showed organizations with higher NPS scores report significantly greater women's representation at every leadership level
Get in touch

Facing a similar challenge?

Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.

© 2026 Sora Life Sciences. All rights reserved.